Valcyte Pulver zur Herstellung einer oralen Lösung

Country: Շվեյցարիա

language: գերմաներեն

source: Swissmedic (Swiss Agency for Therapeutic Products)

active_ingredient:

valganciclovirum

MAH:

CPS Cito Pharma Services GmbH

ATC_code:

J05AB14

INN:

valganciclovirum

pharmaceutical_form:

Pulver zur Herstellung einer oralen Lösung

composition:

valganciclovirum 5 g ut valgancicloviri hydrochloridum, mannitolum 5.78 g, acidum fumaricum, povidonum K 30, aromatica Tutti Frutti, saccharinum natricum, E 211 100 mg, ad pulverem corresp., solutio reconstituta 50 mg/ml corresp. natrium 16.3 mg.

class:

A

therapeutic_group:

Synthetika

therapeutic_area:

Virostaticum

authorization_status:

zugelassen

authorization_date:

2008-10-29